$item.Name

首页>试剂标物>行业专用试剂>生物试剂

CP-456773 MCC950

型号
CP-456773
参数
供货周期:现货 规格:2 mg;5 mg;10 mg 货号:HY-12815 应用领域:生物产业
MedChemExpress LLC

免费会员 

生产厂家

该企业相似产品

SC-560

在线询价

ST 2825

在线询价

BMS-1

在线询价

Dapansutrile

在线询价

Opaganib

在线询价

瑞喹莫德 Resiquimod

在线询价

ARN-3236

在线询价

C-176

在线询价
抑制剂,调节剂,API,天然产物,各种类型化合物库

MedChemExpress (MCE) 专注于为科学家提供高品质的生物活性小分子化合物,化合物库及各类试剂盒,总部位于美国新泽西。
•   MedChemExpress (MCE) 产品作用于 20 多个热门信号通路及研究领域的300多个细分靶点,拥有 10000 特异性抑制剂、激动剂,以及 50 活性化合物筛选库;
•   我们坚持对所有产品进行严格质检,确保产品的高品质和高纯度;
•   MedChemExpress (MCE) 产品已被数万名科学家信赖,并被大量top文献和*引用;
•   我们拥有专业的技术团队追踪前沿科研进展,不断丰富各个靶点的特异性产品,坚持做 “您身边的抑制剂大师”;
•   MedChemExpress (MCE) 与众多药企和科研机构保持深度合作;
•   大量产品有中国库存,工作日 16:00 前订单确保当日发货,次日送达。
MCE 中国站:www.MedChemExpress.cn

Hotline: 400-820-3792
Tel: 021-58955995
Email: sales@MedChemExpress.cn
Tech Support: 021-58950656

MedChemExpress - Inhibitors Agonists

MedChemExpress - Screening Libraries

MedChemExpress - Top Publications Citing Use of MCE

详细信息

MCC950

产品活性:MCC950 是一种有效,选择性的 NLRP3 抑制剂,在BMDMs 和 HMDMs中的IC50 分别为 7.5 nM 和 8.1 nM。

研究领域:Immunology/Inflammation

作用靶点:NOD-like Receptor (NLR)

In Vitro: MCC950 blocks canonical and non-canonical NLRP3 activation at nanomolar concentrations. MCC950 specifically inhibits NLRP3 but not AIM2, NLRC4 or NLRP1 activation. The effect of MCC950 on NLRP3 inflammasome activation is tested in mouse bone marrow derived macrophages (BMDM) and human monocyte derived macrophages (HMDM). The IC50 of MCC950 in BMDM is approximately 7.5 nM, while in HMDM it has a similar inhibitory capacity (IC50=8.1 nM). MCC950 also dose dependently inhibit IL-1β but not TNF-α secretion.MCC950 specifically blocks caspase-11-directed NLRP3 activation and IL-1β secretion upon stimulation of the non-canonical pathway. NLRC4-stimulated IL-1β and TNF-α secretion (as activated by Salmonella typhimurium) are not inhibited by MCC950 even at a concentration of 10 µM. MCC950 does not inhibit caspase-1 activation or IL-1β processing in response to S. typhimurium. The expression of pro-caspase-1 and pro-IL-1β in cell lysates is not substantially affected by MCC950 treatment.

In Vivo: MCC950 reduces Interleukin-1p (IL-1β) production and attenuates the severity of experimental autoimmune encephalomyelitis (EAE), a disease model of multiple sclerosis. Pre-treatment with MCC950 reduces serum concentrations of IL-1β and IL-6 while it does not considerably decrease the amount of TNF-α. Treatment of mice with MCC950 delays the onset and reduced the severity of EAE. Intracellular cytokine staining and FACS analysis of brain mononuclear cells from mice sacrificed on day 22 shows modestly reduced frequencies of IL-17 and IFN-γ producing CD3+ T cells in MCC950 treated mice in comparison with PBS-treated mice. IFN-γ and particularly IL-17 producing cell numbers are also reduced in both the CD4+ and γδ+ sub-populations of CD3+ T cells.

相关产品:MCC950 sodium  |  CY-09  |  NOD-IN-1  |  INF39  |  Troxerutin  |  Nodinitib-1  |  Arglabin  |  Dapansutrile  |  N4-Acetylcytidine triphosphate

1000+ Inhibitors&Agonists 作用于20多条经典信号通路
30+ Screening Libraries 疾病机制研究的高效工具
CCK8 Kit | Cell Counting Kit-8
FDA-Approved 药物筛选库
Inhibitor Cocktails 蛋白酶, 磷酸酶 & 去乙酰化酶
Top Publications Citing Use of MCE
MCE Hotline: 4008203792 | 中国现货 - 文献引用 - 高纯度高品质 - *技术支持

相关技术文章

同类产品推荐

相关分类导航

产品参数

供货周期 现货
规格 2 mg;5 mg;10 mg
货号 HY-12815
应用领域 生物产业
企业未开通此功能
详询客服 : 0571-87858618
提示

请选择您要拨打的电话:

当前客户在线交流已关闭
请电话联系他 :